Skip to main content

Volume 15 - Issue 2 - February, 2003

Commentary
08/01/2008
Douglas M. Cavaye, MD; James P. Zidar, MD; Max Amor, MD; Michael Lawrence-Brown, MD; John Anderson, DPM, FACFAS, MD
John Anderson: In the U.S. and in Australia, stroke is the third leading cause of death and the leading cause of disability. Yet despite this, there is an air of therapeutic nihilism about stroke. Patients who present to the emergency room...
John Anderson: In the U.S. and in Australia, stroke is the third leading cause of death and the leading cause of disability. Yet despite this, there is an air of therapeutic nihilism about stroke. Patients who present to the emergency room...
John Anderson: In the U.S. and...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
Douglas M. Cavaye, MD; James P. Zidar, MD; Max Amor, MD; Michael Lawrence-Brown, MD; John Anderson, DPM, FACFAS, MD
Richard Myler: I have always believed that you don’t read history, you repeat it. You may never have heard about Richard Schneider who was the chief of Werner Forsmann in Germany. In 1929, a 24-year-old man who worked with Schneider had the...
Richard Myler: I have always believed that you don’t read history, you repeat it. You may never have heard about Richard Schneider who was the chief of Werner Forsmann in Germany. In 1929, a 24-year-old man who worked with Schneider had the...
Richard Myler: I have always...
08/01/2008
Journal of Invasive Cardiology
Editorial Message
08/01/2008
Richard E. Shaw, PhD, FACC
Dear Readers, This issue of the Journal of Invasive Cardiology begins another exciting year for the publication of the Journal and includes original research articles, case reports, reviews, articles from the Journal special sections “The...
Dear Readers, This issue of the Journal of Invasive Cardiology begins another exciting year for the publication of the Journal and includes original research articles, case reports, reviews, articles from the Journal special sections “The...
Dear Readers, This issue of the...
08/01/2008
Journal of Invasive Cardiology
Electrophysiology Corner
08/01/2008
Jason M. Lazar, MD; Stephanie Manzella, ANP; Joe Moonjelly, MD; Ella Wirkowski, MD; Todd J. Cohen, MD, FACC, FHRS
QT dispersion (QTD), the difference between the maximum and minimum QT interval on the 12-lead electrocardiogram (ECG), is a marker of heterogeneity of ventricular repolarization.1 Previous studies have shown increased QTD to be a predictor...
QT dispersion (QTD), the difference between the maximum and minimum QT interval on the 12-lead electrocardiogram (ECG), is a marker of heterogeneity of ventricular repolarization.1 Previous studies have shown increased QTD to be a predictor...
QT dispersion (QTD), the...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
C.G. Bahuleyan, DM, K. Sunitha, DM, K. Sivaprasad, Mathew Iype
C.G. Bahuleyan, DM, K. Sunitha, DM, K...
Extensive thrombus in native coronary arteries is relatively rare. Percutaneous revascularization of thrombus-containing lesions has an increased incidence of adverse events, such as abrupt vessel closure and myocardial infarction. The two...
Extensive thrombus in native coronary arteries is relatively rare. Percutaneous revascularization of thrombus-containing lesions has an increased incidence of adverse events, such as abrupt vessel closure and myocardial infarction. The two...
Extensive thrombus in native...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Kais Battikh, MD; Riadh Rihani, MD; Jean Michel Lemahieu, MD
Left main coronary artery (LMCA) disease is found in 3–5% of patients undergoing cardiac catheterization for ischemic chest pain, congestive heart failure or cardiogenic shock.1 Revascularization by coronary artery bypass grafting (CABG) has...
Left main coronary artery (LMCA) disease is found in 3–5% of patients undergoing cardiac catheterization for ischemic chest pain, congestive heart failure or cardiogenic shock.1 Revascularization by coronary artery bypass grafting (CABG) has...
Left main coronary artery (LMCA)...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
M.H. Jim, MD, R.H.W. Chan, MD, S.W.L. Lee, MD
M.H. Jim, MD, R.H.W. Chan, MD, S.W.L....
Chronic total occlusion (CTO) is always a challenge to the interventional cardiologist. The successful recanalization rate is only about 50–70%.1–5 Guidewires always prefer to go to the channel that has the lowest resistance. As a...
Chronic total occlusion (CTO) is always a challenge to the interventional cardiologist. The successful recanalization rate is only about 50–70%.1–5 Guidewires always prefer to go to the channel that has the lowest resistance. As a...
Chronic total occlusion (CTO) is...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Shinji Tanaka, MD, PhD, FACG; Kazuharu Sunami, MD; Shigeru Saito, MD
The incidence of major anomalies of the coronary artery is 0.3–0.8% of the population undergoing coronary angiography.1 There are only a few cases in the literature describing successful percutaneous coronary intervention (PCI) to the...
The incidence of major anomalies of the coronary artery is 0.3–0.8% of the population undergoing coronary angiography.1 There are only a few cases in the literature describing successful percutaneous coronary intervention (PCI) to the...
The incidence of major anomalies...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
S. Sharma, MD; Kewal Krishan Talwar, MD, DM; S. Ramamurthy, MD, DM
Non-specific aorto-arteritis (NSAA) results in stenosing, occlusive and dilatational or aneurysmal lesions involving the aorta, its major branches and the pulmonary arteries in varying combinations and extent.1 Percutaneous balloon...
Non-specific aorto-arteritis (NSAA) results in stenosing, occlusive and dilatational or aneurysmal lesions involving the aorta, its major branches and the pulmonary arteries in varying combinations and extent.1 Percutaneous balloon...
Non-specific aorto-arteritis...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Angela Ferrari, PhD; Bernhard Reimers, MD; Antonio Colombo, MD; Carlo Briguori, MD, PhD; Antonio L. Bartorelli, MD; Flavio Airoldi, MD; Carlo Di Mario, MD, PhD, FESC, FACC, FRCP; Giorgio Gimelli, MD; Francesco Bedogni, MD, PhD; Arian Frasheri, MD; Luigi Inglese, MD; Nino Rubino, MD
In the last decade, coronary stenting has evolved from a bailout procedure following balloon angioplasty into an elective strategy for the treatment of all lesions located in vessels with an angiographic reference diameter larger than 3.0...
In the last decade, coronary stenting has evolved from a bailout procedure following balloon angioplasty into an elective strategy for the treatment of all lesions located in vessels with an angiographic reference diameter larger than 3.0...
In the last decade, coronary...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Wolfgang A. Schöbel, MD; Manfred Mauser, MD
The area of the peripheral puncture site is decreased by 31% with 5 Fr sheaths compared to 6 Fr sheaths (2.2 mm2 vs. 3.1 mm2, respectively), by 49% in comparison with 7 Fr sheaths (4.3 mm2), and by 61% in comparison with 8 Fr sheaths (5.6...
The area of the peripheral puncture site is decreased by 31% with 5 Fr sheaths compared to 6 Fr sheaths (2.2 mm2 vs. 3.1 mm2, respectively), by 49% in comparison with 7 Fr sheaths (4.3 mm2), and by 61% in comparison with 8 Fr sheaths (5.6...
The area of the peripheral...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
Bernhard Meier, MD, FACC, FESC
Percutaneous coronary angioplasty (currently summarized under the term PCI) started 25 years ago with roughly 10 French (Fr) guiding catheters that left no room for contrast medium injection. The actual angioplasty gear (ballon catheter with...
Percutaneous coronary angioplasty (currently summarized under the term PCI) started 25 years ago with roughly 10 French (Fr) guiding catheters that left no room for contrast medium injection. The actual angioplasty gear (ballon catheter with...
Percutaneous coronary...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Dongming Hou, MD, PhD; Keith L. March, MD, PhD
The pericardium is a two-layered fibro-serous sac that encloses the heart and the roots of the great vessels. The potential space normally contains only a small amount of fluid, approximately 15–30 ml, comprised mainly of an ultrafiltrate of...
The pericardium is a two-layered fibro-serous sac that encloses the heart and the roots of the great vessels. The potential space normally contains only a small amount of fluid, approximately 15–30 ml, comprised mainly of an ultrafiltrate of...
The pericardium is a two-layered...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Ioannis Iakovou, MD; George D. Dangas, MD, PhD; Gregg W. Stone, MD, FACC, FSCAI; Roxana Mehran, MD; Gary S. Mintz, MD; Lowell F. Satler, MD; Kenneth M. Kent, MD, PhD; Augusto D. Pichard, MD, FACC, FSCAI; Martin B. Leon, MD; Martin Fahy, MSc; Alexandra J. Lansky, MD; Dale T. Ashby, MBBS, PhD
Contrast-induced nephropathy (CIN) may occur after percutaneous coronary interventions (PCI), particularly in patients with baseline chronic renal failure (CRF) and diabetes mellitus.1–3 We have reported on the adverse impact of CIN post-PCI...
Contrast-induced nephropathy (CIN) may occur after percutaneous coronary interventions (PCI), particularly in patients with baseline chronic renal failure (CRF) and diabetes mellitus.1–3 We have reported on the adverse impact of CIN post-PCI...
Contrast-induced nephropathy...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
David E. Kandzari, MD; Abdallah G. Rebeiz, MD; Andrew L. Wang, MD; Michael H. Sketch, Jr., MD
Contrast-induced nephropathy (CIN) is a well-recognized risk of coronary angiography and percutaneous coronary intervention (PCI), with an overall estimated incidence up to 15% and less than 1% incidence of severe CIN requiring dialysis.1...
Contrast-induced nephropathy (CIN) is a well-recognized risk of coronary angiography and percutaneous coronary intervention (PCI), with an overall estimated incidence up to 15% and less than 1% incidence of severe CIN requiring dialysis.1...
Contrast-induced nephropathy...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Alex S. Yip, MBBS, FRCP; Wing-hing Chow, MBBS, FRCP; Chi-Hang Lee, MD, MBBS, MRCP; Yim-lung Leung, MBChB, MSc; Nim-pong Kwong, MBChB, MRCP; On-hing Kwok, MBBS, MRCP
Patent ductus arteriosus (PDA) is a common congenital cardiac anomaly. Depending on the size of the PDA, patients may be asymptomatic or in heart failure. Treatment is recommended because of the risk of infective endocarditis and congestive...
Patent ductus arteriosus (PDA) is a common congenital cardiac anomaly. Depending on the size of the PDA, patients may be asymptomatic or in heart failure. Treatment is recommended because of the risk of infective endocarditis and congestive...
Patent ductus arteriosus (PDA)...
08/01/2008
Journal of Invasive Cardiology